Alerts will be sent to your verified email
Verify Email
KOBO
|
Kobo Biotech
|
Decipher Labs
|
Zyden Gentec
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.35 % | 11.47 % | 0.0 |
|
5yr average Equity Multiplier
|
4.06 | 1.66 | 2.0 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 1.34 | 0.21 |
|
5yr Avg Net Profit Margin
|
-3.79 % | -2.62 % | -137.59 % |
|
Price to Book
|
0.0 | 0.31 | n/a |
|
P/E
|
0.0 | 0.0 | n/a |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -1572.13 Days | 785.76 Days |
|
Inventory Days
|
89.28 Days | 0.29 Days | 134.34 Days |
|
Days Receivable
|
0.0 | 96.97 Days | 803.05 Days |
|
Days Payable
|
147.48 Days | 2845.41 Days | 421.99 Days |
|
5yr Average Interest Coverage Ratio
|
0.99 | -371.95 | -2.08 |
|
5yr Avg ROCE
|
11.79 % | 3.14 % | -6.92 % |
|
5yr Avg Operating Profit Margin
|
8.83 % | -7.49 % | -95.87 % |
|
5 yr average Debt to Equity
|
1.62 | 0.31 | 0.68 |
|
5yr CAGR Net Profit
|
n/a | n/a | -1.66 % |
|
5yr Average Return on Assets
|
-0.89 % | -1.09 % | -15.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.95 % | 16.43 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -17.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kobo Biotech
|
Decipher Labs
|
Zyden Gentec
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|